InsidersTradesSigma
Track the Hamlet BioPharma AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Hamlet BioPharma AB has logged 9 reports. Market capitalisation: €1.4bn. The latest transaction was disclosed on 25 May 2026 (Sale). Among the most active insiders: Henrik Sundin. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€16,127
1 ops.
Buy Volume
€76,774
8 ops.
Sell Volume
16Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 May 2026
Declarations9 total
10,000 shares@ SEK 7.490.0005% mcap9.0% of flowAktieISIN SE0015661152FI:csv-5b71b289a4ac40e47ab5
20,000 shares@ SEK 7.700.0011% mcap18.3% of flowAktieISIN SE0015661152FI:csv-17884beb14cceb2d6251
20,000 shares@ SEK 7.650.0011% mcap18.2% of flowAktieISIN SE0015661152FI:csv-69bdd949cde8b5d12cf1
10,000 shares@ SEK 7.610.0005% mcap9.1% of flowAktieISIN SE0015661152FI:csv-74c6872ba2c9fa3745f0
10,000 shares@ SEK 7.580.0005% mcap9.0% of flowAktieISIN SE0015661152FI:csv-8b1223654d29b5466fcb
10,000 shares@ SEK 7.630.0005% mcap9.1% of flowAktieISIN SE0015661152FI:csv-628a2bf8649801cf1f97
10,000 shares@ €0.689432.9% of flowAktieISIN SE0015661152FI:A003Z114-1
20,000 shares@ €0.703767.1% of flowAktieISIN SE0015661152FI:A003Z083-1
25,000 shares@ €0.64510.0012% mcap100.0% of flowAktieISIN SE0015661152FI:A003X421-1
9 of 9 declarations
About Hamlet BioPharma AB
Hamlet BioPharma AB is a company focused on developing innovative cancer treatments. It is listed on the XSTO market.